Tomislav bulum (38 resultados)

- Tapa dura
Librería: BargainBookStores, Grand Rapids, MI, Estados Unidos de AmericaBargainBookStores
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 54,66
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: 5 disponibles
Hardback or Cased Book. Condición: New. Recent Advances in Hypertension, Hypercholesterolemia and Type 2 Diabetes. Book.

- Tapa dura
Librería: California Books, Miami, FL, Estados Unidos de AmericaCalifornia Books
Contactar con el vendedorVendedor de 4 estrellasCondición: Nuevo
EUR 56,46
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Condición: New.

- Tapa dura
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de AmericaPBShop.store US
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 56,52
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
HRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.

- Tapa dura
Librería: PBShop.store UK, Fairford, GLOS, Reino UnidoPBShop.store UK
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 53,89
Envío por EUR 4,86Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
HRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.

- Tapa dura
Librería: Rarewaves.com USA, London, LONDO, Reino UnidoRarewaves.com USA
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 60,94
Gastos de envío gratisSe envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Hardback. Condición: New.

- Tapa dura
Librería: California Books, Miami, FL, Estados Unidos de AmericaCalifornia Books
Contactar con el vendedorVendedor de 4 estrellasCondición: Nuevo
EUR 72,35
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Condición: New.

- Tapa dura
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de AmericaPBShop.store US
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 72,85
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
HRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.

- Tapa dura
Librería: PBShop.store UK, Fairford, GLOS, Reino UnidoPBShop.store UK
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 68,69
Envío por EUR 5,87Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
HRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.

- Tapa dura
Librería: California Books, Miami, FL, Estados Unidos de AmericaCalifornia Books
Contactar con el vendedorVendedor de 4 estrellasCondición: Nuevo
EUR 80,29
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Condición: New.

- Tapa dura
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de AmericaPBShop.store US
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 81,03
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
HRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.

- Tapa dura
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de AmericaPBShop.store US
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 81,22
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
HRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.

- Tapa dura
Librería: PBShop.store UK, Fairford, GLOS, Reino UnidoPBShop.store UK
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 76,13
Envío por EUR 6,86Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
HRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.

- Tapa dura
Librería: PBShop.store UK, Fairford, GLOS, Reino UnidoPBShop.store UK
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 76,13
Envío por EUR 6,86Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
HRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.

- Tapa dura
Librería: California Books, Miami, FL, Estados Unidos de AmericaCalifornia Books
Contactar con el vendedorVendedor de 4 estrellasCondición: Nuevo
EUR 86,46
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Condición: New.

- Tapa dura
Librería: Rarewaves.com UK, London, Reino UnidoRarewaves.com UK
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 57,04
Envío por EUR 75,98Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Hardback. Condición: New.

- Tapa dura
- Impresión bajo demanda
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de AmericaGrand Eagle Retail
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 61,47
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: 1 disponibles
Hardcover. Condición: new. Hardcover. Type 2 diabetes, the most prevalent form of diabetes associated with obesity, remains one of the leading global causes of mortality and disability. Type 2 diabetes is usually clustered with other risk factors associated with metabolic syndrome, such as hypertension and hypercholesterolemia.…The central pathophysiological condition connecting these diseases is insulin resistance associated with visceral obesity. Insulin resistance alters systemic lipid metabolism and leads to the development of a characteristic form of dyslipidemia, with high levels of plasma triglycerides, low levels of high-density lipoprotein, and predominance of small, dense low-density lipoprotein. Hypertension is one of the most prevalent chronic conditions worldwide, affecting more than one billion adults and representing a leading risk factor for cardiovascular disease. However, many individuals with hypertension remain undiagnosed, untreated, or inadequately controlled. Strict management of blood pressure, along with optimization of serum lipid levels, body weight, and lifestyle factors such as smoking cessation, is crucial for controlling the global burden of cardiovascular disease and reducing the risk of premature mortality. Although recent trends indicate a decline in all-cause and cardiovascular mortality, the risk remains high, particularly among patients with diabetes. In this context, this Special Issue brings together the latest research and advancements contributing to the understanding and management of hypertension, hypercholesterolemia, and type 2 diabetes. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

- Tapa dura
- Impresión bajo demanda
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de AmericaGrand Eagle Retail
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 72,34
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: 1 disponibles
Hardcover. Condición: new. Hardcover. Since insulin discovery, thousands of lives have been saved, and the life expectancy of people with diabetes has been significantly extended. Since its discovery, insulin has been continuously improved through pharmacological development and optimized for therapeutic purposes, including the…development of intermediate- and long-acting insulins, the ability to produce human insulin, and finally, the development of insulin analogs with improved properties using recombinant DNA technology. Although recent trends show a decline in complications among patients with type 1 diabetes-largely due to improved management practices and advancements in care technologies such as continuous glucose monitoring and modern insulin delivery systems-the risk of microvascular and macrovascular complications remains high. This Reprint offers a comprehensive overview of insulin secretion and action, the development and action of insulin analogs, and their impact on glycemic control and the chronic complications of diabetes. Advances in diabetes treatment have been vast in the 100 years since the discovery of insulin, resulting in extraordinary progress in the development of novel molecules to improve glucose control, simplify insulin regimens, and enhance quality of life. However, insulin remains the only replacement therapy for type 1 diabetes, and this new data presented here may encourage and support further research in this important field. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

- Tapa dura
- Impresión bajo demanda
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de AmericaGrand Eagle Retail
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 80,28
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: 1 disponibles
Hardcover. Condición: new. Hardcover. Diabetes is the fastest-growing global health issue, with diabetic retinopathy (DR) being a common long-term microvascular complication in both type 1 and type 2 diabetes. Despite recent advancements in treatment, which have reduced diabetes-related visual impairment, DR remains the leading…cause of preventable blindness in working-age adults.This Reprint, featuring eight research articles and six reviews, presents the latest molecular research and advances in DR and diabetic macular edema (DME). Topics include genetic susceptibility and the molecular basis of DR, the interrelationship between DR, DME, and diabetic nephropathy, multimodal imaging, functional tests for early DR detection, and improvements in DR screening through artificial intelligence.This Reprint also explores new therapeutic options for DR, including sirolimus-pretreated mesenchymal stem cells, dazotuftide, aldose reductase inhibitors, and the impact of modern antidiabetic treatments on endothelial progenitor cells, which can aid in restoring vascular function. Additionally, the potential role of natural products in DR treatment is examined. This new knowledge promises to enhance diagnosis and may form the basis for future therapeutic approaches. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

- Tapa dura
- Impresión bajo demanda
Librería: Majestic Books, Hounslow, Reino UnidoMajestic Books
Contactar con el vendedorVendedor de 4 estrellasCondición: Nuevo
EUR 75,40
Envío por EUR 7,60Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 4 disponibles
Condición: New. Print on Demand.

- Tapa dura
- Impresión bajo demanda
Librería: Books Puddle, New York, NY, Estados Unidos de AmericaBooks Puddle
Contactar con el vendedorVendedor de 4 estrellasCondición: Nuevo
EUR 80,52
Envío por EUR 3,42Se envía dentro de Estados Unidos de AmericaCantidad disponible: 4 disponibles
Condición: New. Print on Demand.

- Tapa dura
- Impresión bajo demanda
Librería: Biblios, frankfurt am main, HESSE, AlemaniaBiblios
Contactar con el vendedorVendedor de 4 estrellasCondición: Nuevo
EUR 76,74
Envío por EUR 9,95Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 4 disponibles
Condición: New. PRINT ON DEMAND.

- Tapa dura
- Impresión bajo demanda
Librería: CitiRetail, Stevenage, Reino UnidoCitiRetail
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 61,39
Envío por EUR 43,25Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Hardcover. Condición: new. Hardcover. Type 2 diabetes, the most prevalent form of diabetes associated with obesity, remains one of the leading global causes of mortality and disability. Type 2 diabetes is usually clustered with other risk factors associated with metabolic syndrome, such as hypertension and hypercholesterolemia.…The central pathophysiological condition connecting these diseases is insulin resistance associated with visceral obesity. Insulin resistance alters systemic lipid metabolism and leads to the development of a characteristic form of dyslipidemia, with high levels of plasma triglycerides, low levels of high-density lipoprotein, and predominance of small, dense low-density lipoprotein. Hypertension is one of the most prevalent chronic conditions worldwide, affecting more than one billion adults and representing a leading risk factor for cardiovascular disease. However, many individuals with hypertension remain undiagnosed, untreated, or inadequately controlled. Strict management of blood pressure, along with optimization of serum lipid levels, body weight, and lifestyle factors such as smoking cessation, is crucial for controlling the global burden of cardiovascular disease and reducing the risk of premature mortality. Although recent trends indicate a decline in all-cause and cardiovascular mortality, the risk remains high, particularly among patients with diabetes. In this context, this Special Issue brings together the latest research and advancements contributing to the understanding and management of hypertension, hypercholesterolemia, and type 2 diabetes. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.

- Tapa dura
- Impresión bajo demanda
Librería: AussieBookSeller, Truganina, VIC, AustraliaAussieBookSeller
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 72,50
Envío por EUR 31,69Se envía de Australia a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Hardcover. Condición: new. Hardcover. Type 2 diabetes, the most prevalent form of diabetes associated with obesity, remains one of the leading global causes of mortality and disability. Type 2 diabetes is usually clustered with other risk factors associated with metabolic syndrome, such as hypertension and hypercholesterolemia.…The central pathophysiological condition connecting these diseases is insulin resistance associated with visceral obesity. Insulin resistance alters systemic lipid metabolism and leads to the development of a characteristic form of dyslipidemia, with high levels of plasma triglycerides, low levels of high-density lipoprotein, and predominance of small, dense low-density lipoprotein. Hypertension is one of the most prevalent chronic conditions worldwide, affecting more than one billion adults and representing a leading risk factor for cardiovascular disease. However, many individuals with hypertension remain undiagnosed, untreated, or inadequately controlled. Strict management of blood pressure, along with optimization of serum lipid levels, body weight, and lifestyle factors such as smoking cessation, is crucial for controlling the global burden of cardiovascular disease and reducing the risk of premature mortality. Although recent trends indicate a decline in all-cause and cardiovascular mortality, the risk remains high, particularly among patients with diabetes. In this context, this Special Issue brings together the latest research and advancements contributing to the understanding and management of hypertension, hypercholesterolemia, and type 2 diabetes. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.

- Tapa dura
- Impresión bajo demanda
Librería: Majestic Books, Hounslow, Reino UnidoMajestic Books
Contactar con el vendedorVendedor de 4 estrellasCondición: Nuevo
EUR 108,23
Envío por EUR 7,60Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 4 disponibles
Condición: New. Print on Demand.

- Tapa dura
- Impresión bajo demanda
Librería: Books Puddle, New York, NY, Estados Unidos de AmericaBooks Puddle
Contactar con el vendedorVendedor de 4 estrellasCondición: Nuevo
EUR 114,39
Envío por EUR 3,42Se envía dentro de Estados Unidos de AmericaCantidad disponible: 4 disponibles
Condición: New. Print on Demand.

- Tapa dura
- Impresión bajo demanda
Librería: CitiRetail, Stevenage, Reino UnidoCitiRetail
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 77,64
Envío por EUR 43,25Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Hardcover. Condición: new. Hardcover. Since insulin discovery, thousands of lives have been saved, and the life expectancy of people with diabetes has been significantly extended. Since its discovery, insulin has been continuously improved through pharmacological development and optimized for therapeutic purposes, including the…development of intermediate- and long-acting insulins, the ability to produce human insulin, and finally, the development of insulin analogs with improved properties using recombinant DNA technology. Although recent trends show a decline in complications among patients with type 1 diabetes-largely due to improved management practices and advancements in care technologies such as continuous glucose monitoring and modern insulin delivery systems-the risk of microvascular and macrovascular complications remains high. This Reprint offers a comprehensive overview of insulin secretion and action, the development and action of insulin analogs, and their impact on glycemic control and the chronic complications of diabetes. Advances in diabetes treatment have been vast in the 100 years since the discovery of insulin, resulting in extraordinary progress in the development of novel molecules to improve glucose control, simplify insulin regimens, and enhance quality of life. However, insulin remains the only replacement therapy for type 1 diabetes, and this new data presented here may encourage and support further research in this important field. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.

- Tapa dura
- Impresión bajo demanda
Librería: Biblios, frankfurt am main, HESSE, AlemaniaBiblios
Contactar con el vendedorVendedor de 4 estrellasCondición: Nuevo
EUR 110,42
Envío por EUR 9,95Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 4 disponibles
Condición: New. PRINT ON DEMAND.

- Tapa dura
- Impresión bajo demanda
Librería: AussieBookSeller, Truganina, VIC, AustraliaAussieBookSeller
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 92,12
Envío por EUR 31,69Se envía de Australia a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Hardcover. Condición: new. Hardcover. Since insulin discovery, thousands of lives have been saved, and the life expectancy of people with diabetes has been significantly extended. Since its discovery, insulin has been continuously improved through pharmacological development and optimized for therapeutic purposes, including the…development of intermediate- and long-acting insulins, the ability to produce human insulin, and finally, the development of insulin analogs with improved properties using recombinant DNA technology. Although recent trends show a decline in complications among patients with type 1 diabetes-largely due to improved management practices and advancements in care technologies such as continuous glucose monitoring and modern insulin delivery systems-the risk of microvascular and macrovascular complications remains high. This Reprint offers a comprehensive overview of insulin secretion and action, the development and action of insulin analogs, and their impact on glycemic control and the chronic complications of diabetes. Advances in diabetes treatment have been vast in the 100 years since the discovery of insulin, resulting in extraordinary progress in the development of novel molecules to improve glucose control, simplify insulin regimens, and enhance quality of life. However, insulin remains the only replacement therapy for type 1 diabetes, and this new data presented here may encourage and support further research in this important field. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.

- Tapa dura
- Impresión bajo demanda
Librería: CitiRetail, Stevenage, Reino UnidoCitiRetail
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 85,47
Envío por EUR 43,25Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Hardcover. Condición: new. Hardcover. Diabetes is the fastest-growing global health issue, with diabetic retinopathy (DR) being a common long-term microvascular complication in both type 1 and type 2 diabetes. Despite recent advancements in treatment, which have reduced diabetes-related visual impairment, DR remains the leading…cause of preventable blindness in working-age adults.This Reprint, featuring eight research articles and six reviews, presents the latest molecular research and advances in DR and diabetic macular edema (DME). Topics include genetic susceptibility and the molecular basis of DR, the interrelationship between DR, DME, and diabetic nephropathy, multimodal imaging, functional tests for early DR detection, and improvements in DR screening through artificial intelligence.This Reprint also explores new therapeutic options for DR, including sirolimus-pretreated mesenchymal stem cells, dazotuftide, aldose reductase inhibitors, and the impact of modern antidiabetic treatments on endothelial progenitor cells, which can aid in restoring vascular function. Additionally, the potential role of natural products in DR treatment is examined. This new knowledge promises to enhance diagnosis and may form the basis for future therapeutic approaches. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.

- Tapa dura
- Impresión bajo demanda
Librería: CitiRetail, Stevenage, Reino UnidoCitiRetail
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 85,47
Envío por EUR 43,25Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Hardcover. Condición: new. Hardcover. Diabetes is one of the most challenging health problems in the 21st century, projected to affect 700 million people by 2045. In the last 15 years, the number of people diagnosed with type 1 diabetes increased by 45%, and those diagnosed with type 2 diabetes increased by 95%. The most devasta…ting effects of diabetes are its chronic complications, which confer a high risk of morbidity and mortality and an increased health system cost burden. Although there is increased awareness and new therapeutic options in the treatment of diabetes, it is still the leading cause of blindness in working-age adults, the leading cause of kidney failure and dialysis, and the leading cause of nontraumatic lower-limb amputations.This Special Issue, featuring thirteen research articles, three reviews, and one systematic review, presents the latest knowledge of diabetes and its complications. Topics include the connection between circulating isthmin-1 levels and diabetes, material technologies for improved diabetic foot ulcer treatment, depression and stress in type 2 diabetes, metformin in gestational diabetes, safety of semaglutide and tirzepatide in type 2 diabetes, and aging-related biomarkers in diabetic nephropathy. The Special Issue also explores associations between serum cytokines and growth factors with time in range, as well as progression of diabetic kidney disease and gastrointestinal symptoms in subjects with type 1 diabetes.This new knowledge promises to enhance diagnosis, reduce the rate of progression of diabetes-related chronic complications, and may form the basis for future therapeutic approaches. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.